NGNE
#2778
Neurogene Inc. - Common Stock
39.0 8 USD
+0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+1.98%
Variación mensual
+30.27%
Variación en los últimos 6 meses
+116.75%
Cambio anual
+32.83%
Cierres anteriores
38.3 2
Open
39.0 8
Mínimo
39.0 8
High
39.0 8
Volumen
35
Financials
- Market Capitalization 617.54 M
- Employee 131
- Founded 2018
- CEO Jonathan Drachman M.D.
- Website www.neurogene.com
- Headquarter New York, United States
- FIGI BBG005Y0QDK1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-4.86
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2769 |  PRME Prime Medicine, Inc. - Common Stock | 3.47 USD | -1.42% | -19.30% | +19.66% | -18.74% | 626.74 M USD | ||
| 2771 |  MDXG MiMedx Group, Inc - Common Stock | 4.20 USD | +2.94% | +1.20% | +14.13% | -33.65% | 625.57 M USD | ||
| 2782 |  GYRE Gyre Therapeutics, Inc. - Common Stock | 6.34 USD | 0.00% | -7.17% | +8.93% | -23.24% | 615.16 M USD | ||
| 2786 |  FDMT 4D Molecular Therapeutics, Inc. - Common Stock | 11.70 USD | +3.54% | -4.88% | +27.31% | +3.54% | 611.63 M USD |